JNCCN Journal of the National Comprehensive Cancer Network · Published 2026-06-16 · DOI 10.6004/jnccn.2026.7014
Pietro Scilipoti, Mario de Angelis, Constance Thibault, Aleksander Ślusarczyk, Francesco del Giudice, Roberto Contieri, Rodolfo Hurle, José Daniel Subiela, Giuseppe Simone, Flavia Proietti, Keiichiro Mori, Shahrokh Shariat, David D’Andrea, Stefania Zamboni, Nazareno Suardi, Hajime Tanaka, Shunya Matsumoto, Yasuhisa Fujii, Riccardo Bertolo, Alessandro Antonelli, Elliott Diamant, Dimitri Vordos, Pierre-Etienne Gabriel, Théo Harber, Marc Colombel, Paul Hanquiez, Vera Chatain, Igor Duquesne, Mihnea Bogdan Borz, Gregory Verhoest, Anne Mauger De Varennes, Louis Surlemont, Marion Ghenassia, Alexandra Masson-Lecomte, Arthur Peyrottes, Cédric Lebacle, Peter Beniac, Priscilla Léon, Stéphane Larré, Fayek Taha, Gautier Marcq, Aleksandra Szostek, Benjamin Pradere, Giorgio Calleris, François Audenet, Evanguelos Xylinas, Yves Allory, Anne-Sophie Bajeot, Doriane Prost, Elisabeth Grobet-Jeandin, Francesco Montorsi, Andrea Necchi, Alberto Briganti, Marco Moschini, Mathieu Roumiguié, Morgan Rouprêt, Thomas Seisen
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Scilipoti, P., Angelis, M., Thibault, C., et al. (2026). Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer. JNCCN Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2026.7014